97 related articles for article (PubMed ID: 2449810)
1. Nature and antigen-specific activities of transfer factor against herpes simplex virus type 1.
Huang LL; Su CZ; Wan ZF
Acta Virol; 1987 Nov; 31(6):449-57. PubMed ID: 2449810
[TBL] [Abstract][Full Text] [Related]
2. Isolation and purification of HSV-1 specific transfer factor produced by HSV-1 immunized goat leukocyte dialysate.
Qi HY; Wan ZF; Su CZ
Acta Virol; 1992 May; 36(3):231-8. PubMed ID: 1360750
[TBL] [Abstract][Full Text] [Related]
3. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
Kohl S; Loo LS
J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
[TBL] [Abstract][Full Text] [Related]
4. Frequency of herpes simplex virus-specific helper T lymphocyte precursors in the lymph node cells of infected mice.
Prymowicz D; Moore RN; Rouse BT
J Immunol; 1985 Apr; 134(4):2683-8. PubMed ID: 2579150
[TBL] [Abstract][Full Text] [Related]
5. [Determination of antigen-dependent activity of human lung cancer transfer factor by H3-leucine leucine leukocyte adherence inhibition assay].
Xu WM
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):116-8. PubMed ID: 1377621
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay.
Borkowsky W; Suleski P; Bhardwaj N; Lawrence HS
J Immunol; 1981 Jan; 126(1):80-2. PubMed ID: 6161170
[TBL] [Abstract][Full Text] [Related]
7. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
Kutinová L; Vonka V; Slichtová V
Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
[TBL] [Abstract][Full Text] [Related]
9. Protective immunization of mice with specific HSV-1 glycoproteins.
Chan WL
Immunology; 1983 Jun; 49(2):343-52. PubMed ID: 6303950
[TBL] [Abstract][Full Text] [Related]
10. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
[TBL] [Abstract][Full Text] [Related]
11. Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone.
Leung KN; Nash AA; Sia DY; Wildy P
Immunology; 1984 Dec; 53(4):623-33. PubMed ID: 6209206
[TBL] [Abstract][Full Text] [Related]
12. Chemical characterization of the purified component of specific transfer factor in the leukocyte dialysates from HSV-1 immunized goats.
Qi HY; Wan ZF; Su CZ
Acta Virol; 1992 May; 36(3):239-44. PubMed ID: 1360751
[TBL] [Abstract][Full Text] [Related]
13. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
[TBL] [Abstract][Full Text] [Related]
14. Modified-self-induced modulation of the immune response to herpes simplex virus: effect on antibody formation, cytotoxic T lymphocyte induction, and survival.
Wilson LA; Karabin JM; Smith JW; Dawson D; Scott DW
J Immunol; 1984 Mar; 132(3):1522-8. PubMed ID: 6198395
[TBL] [Abstract][Full Text] [Related]
15. Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells.
Schrier RD; Ishioka GY; Pizer LI; Moorhead JW
J Immunol; 1985 May; 134(5):2889-93. PubMed ID: 2580006
[TBL] [Abstract][Full Text] [Related]
16. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
Schmid DS; Rouse BT
J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
[TBL] [Abstract][Full Text] [Related]
17. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA
J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234
[TBL] [Abstract][Full Text] [Related]
18. Acute morphine administration reduces white blood cells' capability to induce innate resistance against HSV-1 infection in BALB/c mice.
Jamali A; Bamdad T; Soleimanjahi H; Pakdel FG; Arefian E
Neuroimmunomodulation; 2007; 14(1):16-23. PubMed ID: 17700036
[TBL] [Abstract][Full Text] [Related]
19. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
